Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
MUMBAI, India and NAPLES, Fla., June 3, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and its alliance partner Natco Pharma Limited (Natco) today announced the approval from the United States Food and Drug...
MUMBAI, India and NAPLES, Fla., June 3, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and its alliance partner Natco Pharma Limited (Natco) today announced the approval from the United States Food and Drug...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.